AZN ▲ +0.6% - AstraZeneca PLC $AZN ZEGFROVY® (sunvozertinib) now available in the US for patients with previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations 22-OCT-2026 08:10 AM ET